The story behind the female sex pill

The FDA has twice rejected the little pink pill that's designed to improve the sex lives of women, saying its benefits were small and its risks significant. But earlier this month, an advisory panel cleared the way for the FDA to approve it as soon as this summer. Some say that's due to the clever marketing of drug maker Sprout Pharmaceuticals, which organized women's groups in an intense lobbying effort. In this excerpt from America Tonight, Lori Jane Gliha investigates the curious coalition behind the push for approval.